Harbor Asset Planning »

Takeda Pharmaceutical shares owned by Harbor Asset Planning

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by Harbor Asset Planning from 13F filings

Historical chart of Harbor Asset Planning investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by Harbor Asset Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by Harbor Asset Planning

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.4k 235 14.64

More positions owned by Harbor Asset Planning

Vanguard Index Fds Total Stk Mkt (VTI)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Vanguard Index Fds Value Etf (VTV)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
Goldman Sachs Etf Tr Activebeta Int (GSIE)
Invesco Exchange Traded Fd T S&p500 Eql Ind (RSPN)
Vanguard World Inf Tech Etf (VGT)
Invesco Exchange Traded Fd T S&p Mdcp Quality (XMHQ)
Ishares Tr Us Sml Cap Eqt (SMLF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Amplify Etf Tr Cwp Enhanced Div (DIVO)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Fidelity Covington Trust Msci Finls Idx (FNCL)
Vanguard Index Fds Sml Cp Grw Etf (VBK)

View all positions for Harbor Asset Planning

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Morgan Stanley
UBS Group
Goldman Sachs Group
FMR
Brandes Investment Partners
Renaissance Technologies
BlackRock
Toronto-Dominion Bank
Arrowstreet Capital, Limited Partnership
Millennium Management
First Trust Advisors
Northern Trust
Qube Research & Technologies
Citadel Advisors

View all funds holding Takeda Pharmaceutical